SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy
… adverse events (irAEs). These irAEs are unique and are different to those of traditional cancer therapies, and typically have delayed onset and prolonged duration. Some of them can be severe and … mandatory and multidisciplinary assessment boards have been set up in cancer centers. Because management of irAEs …
Published on: